Pulmonary Hypertension
Conditions
Brief summary
The study hypothesis is that accuracy of CO measurement by IGR does not differ from classical CO measurement methods such as thermodilution or direct Fick method. This is why the study aims to determine whether non invasive cardiac output (CO) measurement using inert gas rebreathing (IGR)is a suitable method in patients with pulmonary hypertension. In order to examine this, the IGR method will be used in patients undergoing diagnostic or follow-up right heart catheterization.
Detailed description
Inert Gas Rebreathing method enables non invasive measurement of cardiac output (CO) using the single rebreathing method. A mixture of blood soluble (N2O) and blood insoluble gas (SF6) and environmental air is inhaled and the amount of N2O, SF6, O2 and CO2 is measured by a photoacoustic analysator. The length of a measurement is about 1 minute. As the gold standard measurement of CO is performed invasively, there is an urgent need for the development of non-invasive tools like IGR.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Written informed consent * Patients who undergo right heart catheterization
Exclusion criteria
* Missing written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiac output | at baseline |
Countries
Austria